Țară: Irlanda
Limbă: engleză
Sursă: HPRA (Health Products Regulatory Authority)
Citalopram
PCO Manufacturing Ltd.
N06AB; N06AB04
Citalopram
20 milligram(s)
Film-coated tablet
Product subject to prescription which may not be renewed (A)
Selective serotonin reuptake inhibitors; citalopram
Authorised
2001-08-24
_ _ _ _ _ _ PACKAGE LEAFLET: INFORMATION FOR THE USER CIPRAMIL ® 20 MG FILM-COATED TABLETS citalopram READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START TAKING THIS MEDICINE BECAUSE IT CONTAINS IMPORTANT INFORMATION FOR YOU. Keep this leaflet. You may need to read it again. If you have any further questions, ask your doctor or pharmacist. This medicine has been prescribed for you. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours. If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. See section 4. WHAT IS IN THIS LEAFLET 1. What Cipramil is and what it is used for 2. What you need to know before you take Cipramil 3. How to take Cipramil 4. Possible side effects 5. How to store Cipramil 6. Contents of the pack and other information 1. WHAT CIPRAMIL IS AND WHAT IT IS USED FOR HOW DOES CIPRAMIL WORK Cipramil belongs to a group of antidepressants called Selective Serotonin Reuptake Inhibitors (SSRIs). These medicines act on the serotonin-system in the brain by increasing the serotonin level. Disturbances in the serotonin-system are considered an important factor in the development of depression and related diseases. WHAT IS CIPRAMIL USED FOR Cipramil contains citalopram and is used for the treatment of depression and when you feel better, to help prevent these symptoms recurring. Further, Cipramil is used for long-term treatment to prevent the occurrence of new depressive episodes in patients who have recurrent depression. Cipramil is also beneficial in relieving symptoms in patients prone to panic attacks. Ask your doctor if you have any questions about why Cipramil has been prescribed for you. 2. WHAT YOU NEED TO KNOW BEFORE YOU TAKE CIPRAMIL DO NOT TAKE CIPRAMIL: if you are allergic to citalopram or any of the other ingredients of this medicine (listed in section 6) if you take other medicines which belong to a group called monoamine oxidase inhibitors (MAOIs). Citiți documentul complet
Health Products Regulatory Authority 26 November 2019 CRN009G03 Page 1 of 2 SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Cipramil 20 mg film-coated tablets 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each tablet contains 20 mg citalopram (as citalopram hydrobromide). Excipient(s) with known effect: lactose monohydrate. For the full list of excipients, see section 6.1. 3 PHARMACEUTICAL FORM Film-coated tablet _Product imported from Spain, United Kingdom, France, Hungary, The Netherlands and Italy:_ White, oval-shaped tablets plain on one side and with a breakline on the other side.‘C’ is debossed to the left of the breakline and ‘N’ is debossed to the right of the breakline. 4 CLINICAL PARTICULARS As per PA0776/001/002 5 PHARMACOLOGICAL PROPERTIES As per PA0776/001/002 6 PHARMACEUTICAL PARTICULARS 6.1 LIST OF EXCIPIENTS Maize starch Lactose monohydrate Cellulose, microcrystalline Copovidone Glycerol 85% Croscarmellose sodium Magnesium stearate Hypromellose Macrogol 400 Titanium dioxide (E 171) 6.2 INCOMPATIBILITIES Not applicable. 6.3 SHELF LIFE The shelf life expiry date of this product shall be the date shown on the blister pack and outer package of the product on the market in the country of origin. 6.4 SPECIAL PRECAUTIONS FOR STORAGE Do not store above 25 ° C. Health Products Regulatory Authority 26 November 2019 CRN009G03 Page 2 of 2 Store in the original package in order to protect from light. 6.5 NATURE AND CONTENTS OF CONTAINER Blister packs of 28 tablets in a cardboard outer carton or an overlabelled outer carton. 6.6 SPECIAL PRECAUTIONS FOR DISPOSAL OF A USED MEDICINAL PRODUCT OR WASTE MATERIALS DERIVED FROM SUCH MEDICINAL PRODUCT AND OTHER HANDLING OF THE PRODUCT No special requirements. 7 PARALLEL PRODUCT AUTHORISATION HOLDER PCO Manufacturing Ltd. Unit 10, Ashbourne Business Park Rath Ashbourne Co. Meath Ireland 8 PARALLEL PRODUCT AUTHORISATION NUMBER PPA0465/068/002 9 DATE OF FIRST AUTHORISATION/RENEWAL OF THE AUTHORISATION Date of first authorisation: 24 August 2001 Dat Citiți documentul complet